Generate an explanation for the given claim using the provided supporting material from the paragraph. Please consider the following points while generating an output. 1) The claim will always have supporting proof in the paragraph, and the paragraph will have a clear point of view supporting the claim. 2) There can be instances where direct correlation to the claim is not available. Make use of the sentences in the paragraph to provide a corresponding output supporting the claim. 3) The explanation should be at least one and at most twelve sentences long.

Paragraph: Prime Minister Shinzo Abe declared a state of emergency in Tokyo and six other prefectures last week in response to the coronavirus outbreak. While many businesses in Tokyo and elsewhere are now shut, most convenience stores have stayed open as they are considered essential. There are around 58,000 convenience stores throughout Japan. Most are open 24 hours and sell everything from pre-made bento lunches to beer and neckties. They also offer package delivery and bill payment services. “I actually feel safer,” said 53-year-old restaurant owner Isao Otsuka, who was shopping at one of the roughly 150 7-Eleven stores, mainly in Tokyo, that have installed the transparent plastic curtains. 7-Eleven’s owner, Seven & i Holdings, has asked convenience store workers to wear masks, check their temperatures, wash their hands frequently and sterilise surfaces. The new coronavirus spreads from person to person through small droplets from the nose or mouth via coughing or sneezing, according to the World Health Organization. Scientists have also said the virus can remain infectious in droplets in the air for hours and on surfaces for days. Japan had recorded 7,411 cases of infection and 138 deaths from the virus as of Monday, public broadcaster NHK said, with more than 2,000 cases in Tokyo, a sharp rise from late March. Claim: With plastic sheets, Japan's convenience stores target social distancing.
Some of Japan’s ubiquitous convenience stores have taken a novel approach to social distancing by hanging plastic sheets from the ceiling to provide a barrier between customers and staff at the cash register during the coronavirus pandemic.

Paragraph: Jason Wahl, director of the Division of Medical Marijuana, says opening the final dispensary is a milestone for the program. The state has issued more than 1,850 identification cards to qualifying patients, Wahl said. North Dakota is the first in the nation to add an electronic card option for patients, caregivers and agents of dispensaries and manufacturing facilities. Other dispensaries are located in Bismarck, Devils Lake, Fargo, Jamestown, Grand Forks, Minot and Williston. For a qualifying patient or designated caregiver to enter the display area of a dispensary, they must have their registry identification card. Claim: Eighth, final medical marijuana dispensary opening in ND.
The final medical marijuana dispensary is set to open this week in North Dakota. The eighth dispensary is expected to open in Dickinson on Friday.

Paragraph: The letter, sent by J&J’s Tibotec Therapeutics unit to doctors this month, cited cases of drug-induced hepatitis as well as liver injury and death. “We are issuing a new warning on our labeling,” Tibotec Therapeutics spokeswoman Pam Van Houten told Reuters. The company said in its letter that the problems have not been linked directly to Prezista, a once-daily protease inhibitor that was given in combination with the drug ritonavir. Ritonavir is sold by Abbott Laboratories under the name Norvir. Fifteen cases of liver problems were reported during clinical trials, Van Houten said. She added the company did not provide information on post-marketing cases reported after the drug’s U.S. approval in 2006. Most of the cases occurred in patients with advanced HIV, who were taking multiple medications, as well as those who were also infected with hepatitis B or C, the letter said. The letter and Van Houten did not say how many liver-related deaths occurred. The FDA warning was released on its Web site here Claim: J&J, FDA warn of liver risk with HIV drug patients.

Johnson & Johnson and the U.S. Food and Drug Administration warned of reported liver damage and death in patients taking the company’s HIV drug Prezista, according to a letter released on Wednesday.